RERCX American Funds EUPAC R-3 Forecast, Technical & Fundamental Analysis

The most notable companies in this group are AstraZeneca PLC (NYSE:AZN).

The investment seeks long-term growth of capital. The fund invests primarily in common stocks in Europe and the Pacific Basin that the investment adviser believes have the potential for growth. Growth stocks are stocks that the investment adviser believes have the potential for above-average capital appreciation. It normally will invest at least 80% of its net assets in securities of issuers in Europe and the Pacific Basin. The fund may invest a portion of its assets in common stocks and other securities of companies in emerging markets.

The average market capitalization across the American Funds EUPAC R-3 MF is 107.49B. The market cap for tickers in the group ranges from 4.54B to 637.35B. ASML holds the highest valuation in this group at 637.35B. The lowest valued company is AIR at 4.54B.

The average weekly volume growth across all stocks in the American Funds EUPAC R-3 MF was 8%. For the same stocks of the MF, the average monthly volume growth was 38% and the average quarterly volume growth was -52%